JMI Syringes & Medical Devices Limited (DSE:JMISMDL)
119.10
-1.10 (-0.92%)
At close: Dec 4, 2025
DSE:JMISMDL Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Cash & Equivalents | 24.7 | 82.96 | 43.16 | 51.71 | 91.72 | 45.78 | Upgrade
|
| Cash & Short-Term Investments | 24.7 | 82.96 | 43.16 | 51.71 | 91.72 | 45.78 | Upgrade
|
| Cash Growth | -36.55% | 92.21% | -16.53% | -43.62% | 100.34% | 60.41% | Upgrade
|
| Accounts Receivable | 600.98 | 636.27 | 573.04 | 466.46 | 490.93 | 566.2 | Upgrade
|
| Receivables | 600.98 | 636.27 | 573.04 | 466.46 | 525.91 | 634.38 | Upgrade
|
| Inventory | 752.76 | 660.75 | 710.2 | 837.05 | 723.95 | 541.64 | Upgrade
|
| Other Current Assets | 362.66 | 321.61 | 241.61 | 192.58 | 596.39 | 434.52 | Upgrade
|
| Total Current Assets | 1,741 | 1,702 | 1,568 | 1,548 | 1,938 | 1,656 | Upgrade
|
| Property, Plant & Equipment | 1,316 | 1,329 | 1,387 | 1,448 | 1,481 | 1,460 | Upgrade
|
| Other Intangible Assets | 1.88 | 1.98 | 2.47 | 2.41 | 0.84 | 0.7 | Upgrade
|
| Other Long-Term Assets | - | - | -0 | 0 | - | - | Upgrade
|
| Total Assets | 3,059 | 3,033 | 2,957 | 2,999 | 3,420 | 3,117 | Upgrade
|
| Accounts Payable | - | 63.09 | 57.06 | 99.99 | 119.06 | 62.16 | Upgrade
|
| Accrued Expenses | 0.46 | 43.38 | 53.43 | 66.03 | 101.8 | 23.83 | Upgrade
|
| Short-Term Debt | 39.18 | 24.41 | 46.13 | 126.46 | 208.48 | 48.4 | Upgrade
|
| Current Portion of Long-Term Debt | 0.82 | 0.87 | 0.81 | 2.01 | 3.31 | 5.15 | Upgrade
|
| Current Portion of Leases | - | - | 0.68 | 2.54 | 5.19 | 8.53 | Upgrade
|
| Current Income Taxes Payable | 168.56 | 164.67 | 90.41 | - | 105.15 | 141.41 | Upgrade
|
| Other Current Liabilities | 133 | 3.38 | 2.22 | 5.12 | 34.06 | 10.13 | Upgrade
|
| Total Current Liabilities | 342.02 | 299.81 | 250.73 | 302.14 | 577.05 | 299.6 | Upgrade
|
| Long-Term Debt | - | 0.16 | 1.03 | 1.83 | 1.37 | 4.91 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 110.4 | 111.13 | 100.57 | 98.79 | 95.48 | 100.8 | Upgrade
|
| Total Liabilities | 452.42 | 411.1 | 352.33 | 402.77 | 673.9 | 405.31 | Upgrade
|
| Common Stock | 300.56 | 300.56 | 300.56 | 300.56 | 221 | 221 | Upgrade
|
| Additional Paid-In Capital | 1,708 | 1,708 | 1,708 | 1,708 | 1,708 | 1,708 | Upgrade
|
| Retained Earnings | 249.3 | 261.53 | 237.17 | 220.1 | 440.95 | 397.54 | Upgrade
|
| Comprehensive Income & Other | 348.63 | 351.3 | 358.61 | 366.86 | 375.53 | 384.64 | Upgrade
|
| Shareholders' Equity | 2,607 | 2,622 | 2,605 | 2,596 | 2,746 | 2,712 | Upgrade
|
| Total Liabilities & Equity | 3,059 | 3,033 | 2,957 | 2,999 | 3,420 | 3,117 | Upgrade
|
| Total Debt | 40 | 25.44 | 48.64 | 132.84 | 218.36 | 66.98 | Upgrade
|
| Net Cash (Debt) | -15.3 | 57.52 | -5.48 | -81.13 | -126.64 | -21.2 | Upgrade
|
| Net Cash Per Share | -0.51 | 1.91 | -0.18 | -2.70 | -4.21 | -0.71 | Upgrade
|
| Filing Date Shares Outstanding | 30.06 | 30.06 | 30.06 | 30.06 | 30.06 | 30.06 | Upgrade
|
| Total Common Shares Outstanding | 30.06 | 30.06 | 30.06 | 30.06 | 30.06 | 30.06 | Upgrade
|
| Working Capital | 1,399 | 1,402 | 1,317 | 1,246 | 1,361 | 1,357 | Upgrade
|
| Book Value Per Share | 86.73 | 87.23 | 86.66 | 86.37 | 91.36 | 90.22 | Upgrade
|
| Tangible Book Value | 2,605 | 2,620 | 2,602 | 2,594 | 2,745 | 2,711 | Upgrade
|
| Tangible Book Value Per Share | 86.67 | 87.16 | 86.58 | 86.29 | 91.33 | 90.19 | Upgrade
|
| Land | 291.9 | 291.9 | 363.56 | 363.56 | 363.56 | 363.56 | Upgrade
|
| Buildings | 785.22 | 783.84 | 707.17 | 704.96 | 701.88 | 683.8 | Upgrade
|
| Machinery | 1,209 | 1,207 | 1,204 | 1,203 | 1,162 | 1,084 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.